Engineering Euglena gracilis as a heterologous protein expression system for the production of COVID19 vaccines and diagnostic antigens
- Funded by Natural Sciences and Engineering Research Council of Canada (NSERC)
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Start & end year
N/AKnown Financial Commitments (USD)
$37,901.2Funder
Natural Sciences and Engineering Research Council of Canada (NSERC)Principal Investigator
Neil EmeryResearch Location
CanadaLead Research Institution
TrentResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnosticsResearch Subcategory
DiagnosticsSpecial Interest Tags
N/AStudy Type
Non-ClinicalClinical Trial Details
N/ABroad Policy Alignment
PendingAge Group
Not ApplicableVulnerable Population
Not applicableOccupations of Interest
Not applicable
Abstract
Biomedical engineering; Life sciences (including biotechnology)